samedan logo
 
 
spacer
home > pmps > summer 2021 > roundtable: vial labelling and packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Roundtable: Vial Labelling and Packaging

Over the last 12 months, a global effort has been made with close collaboration between pharmaceutical companies of all shapes, sizes, and geographies to find a vaccine to tackle the COVID-19 pandemic.

As a testament to the work of the global pharma industry, we now have a number of vaccines approved for use in the US, UK, EU, and many other countries around the world, and a number of others are in late-stage development. Vaccination programmes are accelerating in major nations, and diplomatic efforts are under way to support emerging markets and smaller economies in immunising their populations.

With so many vaccines now approved, and more on the way, global demand for vial fill-finish for completed vaccine doses, as well as secondary packaging services, is surging. We are even seeing growth in demand for filling of COVID-19 pre-filled syringes, as companies look to make it as easy and quick as possible for healthcare providers to vaccinate individuals in order to speed up vaccination programmes (1).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Marcelo Cruz is Director Business Development and Marketing at Tjoapack. With over a decade of experience in the pharma industry, and over 15 years of driving global strategic marketing and sales, Marcelo is responsible for the overall business development strategy and organic growth activities at Tjoapack. In his role, he also leads the development and implementation of inbound and outbound marketing strategies to accelerate lead generation and drive the wider commercial strategy for the business.

Lars Skole is the Managing Director of LSS (Labelling Systems Scandinavia) and has over 15 years’ experience leading technology companies and 12 years devoted solely to the packaging industry. Lars has a great depth of experience in integrating labelling technologies and systems to create high-performance packaging operations. Leveraging an MSc Technology Management degree from the University of Aalborg, Denmark, Lars has experience developing comprehensive labelling solutions for global pharma markets and products including parenterals, pre-filled syringes, auto-injectors, and combination devices.

Anniina Kujala is the Pharmaceutical Product Manager in EMEIA for UPM Raflatac and is responsible for the product management of labelling laminates for pharma and healthcare end uses. Before joining UPM Raflatac, Anniina spent several years working for various global packaging companies in pulp, paper, and cardboard manufacturing, such as UPM Specialty Papers, Stora Enso, and Metsä Board. Anniina is responsible for launching multiple industry-first sustainable labelling solutions, such as wood-based PP and PE plastic labels made from pulp production residues, and PP and PE plastic labels containing recycled content.

Alexander Schäfer has spent his entire career in the contract manufacturing space working his way from the personal care sector into the pharmaceutical industry. His experience includes positions in purchasing before changing to sales and marketing where he has worked for over two decades. Alexander joined Sharp Services seven years ago, and has extensive expertise in contract packaging and serialisation services.
spacer
Marcelo Cruz
spacer
spacer
spacer
Lars Skole
spacer
spacer
spacer
Anniina Kujala
spacer
spacer
spacer
Alexander Schäfer
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Five methods for reducing pharmaceutical cargo theft

In North America, five percent of cargo thefts that occurred in 2020 were pharmaceutical products and 74 percent of all cargo theft occurred in transit, according to the BSI and TT Club Cargo Theft Report 2021. In the US and Canada, the biggest threat comes when containers or trailers are parked at insecure locations, as those were the most exploited vulnerabilities last year. Market dynamics also changed due to Covid-19, as demonstrated by the fact that the theft of stolen cargo in the form of medical supplies such as PPE, increased by more than 5,000 per cent in 2020, compared to 2019.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement